CR Double-Crane(SH:600062) Xin Lang Zheng Quan·2025-12-25 10:15Core Viewpoint - China Resources Double Crane Pharmaceutical Co., Ltd. announced a share repurchase and cancellation of restricted stocks, resulting in a reduction of registered capital to 1.039 billion yuan [1][2]. Group 1: Share Repurchase and Capital Adjustment - The company will repurchase and cancel 174,998 shares of restricted stock granted to three incentive targets, which is approximately 175,000 shares [2]. - Following the repurchase, the total number of shares will be adjusted to 1,038,582,511 shares (1.039 billion shares), and the registered capital will decrease to 1,038,582,511 yuan (1.039 billion yuan) [2]. Group 2: Creditor Notification and Claims - Creditors have 45 days from the announcement date to claim debts or request guarantees, with claims to be submitted to a specified address in Beijing [3]. - Required documentation for claims includes contracts and proof of debt, with additional requirements for corporate and individual creditors [3]. - The company emphasizes compliance with legal regulations to protect creditors' rights during the capital reduction process [3].